Global Erythromycin Thiocyanate Market Research Report 2023

Publication ID:

PB503230691

Publication Date:

March 1, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Erythromycin thiocyanate is a macrolide antibiotic and is a thiocyanate of erythromycin. Can be used for Gram-positive bacteria and Mycoplasma infection; more as the initial raw material for the synthesis of macrolide antibiotics such as erythromycin, roxithromycin, azithromycin, clarithromycin.
The global Erythromycin Thiocyanate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Erythromycin Thiocyanate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Erythromycin Thiocyanate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Erythromycin Thiocyanate include Kelun Chuanning Biotechnology, Ercros S.A., HEC Group, Envee Drugs Pvt Ltd, Mehta Api, Abbvie, Ningxia Qiyuan, Calyx C & P and Alembic Pharma, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erythromycin Thiocyanate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythromycin Thiocyanate.
The Erythromycin Thiocyanate market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Erythromycin Thiocyanate market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erythromycin Thiocyanate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Kelun Chuanning Biotechnology
Ercros S.A.
HEC Group
Envee Drugs Pvt Ltd
Mehta Api
Abbvie
Ningxia Qiyuan
Calyx C & P
Alembic Pharma
SM Biomed
Anuh Pharma
Segment by Type
Purity <90%
90% 鈮� Purity 鈮� 95%
Purity> 95%
Segment by Application
Human Medication
Veterinary Medication
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erythromycin Thiocyanate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Erythromycin Thiocyanate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Erythromycin Thiocyanate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Erythromycin Thiocyanate Market Overview
1.1 Product Definition
1.2 Erythromycin Thiocyanate Segment by Type
1.2.1 Global Erythromycin Thiocyanate Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Purity <90%
1.2.3 90% 鈮� Purity 鈮� 95%
1.2.4 Purity> 95%
1.3 Erythromycin Thiocyanate Segment by Application
1.3.1 Global Erythromycin Thiocyanate Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Human Medication
1.3.3 Veterinary Medication
1.4 Global Market Growth Prospects
1.4.1 Global Erythromycin Thiocyanate Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Erythromycin Thiocyanate Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Erythromycin Thiocyanate Production Estimates and Forecasts (2018-2029)
1.4.4 Global Erythromycin Thiocyanate Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Erythromycin Thiocyanate Production Market Share by Manufacturers (2018-2023)
2.2 Global Erythromycin Thiocyanate Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Erythromycin Thiocyanate, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Erythromycin Thiocyanate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Erythromycin Thiocyanate Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Erythromycin Thiocyanate, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Erythromycin Thiocyanate, Product Offered and Application
2.8 Global Key Manufacturers of Erythromycin Thiocyanate, Date of Enter into This Industry
2.9 Erythromycin Thiocyanate Market Competitive Situation and Trends
2.9.1 Erythromycin Thiocyanate Market Concentration Rate
2.9.2 Global 5 and 10 Largest Erythromycin Thiocyanate Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Erythromycin Thiocyanate Production by Region
3.1 Global Erythromycin Thiocyanate Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Erythromycin Thiocyanate Production Value by Region (2018-2029)
3.2.1 Global Erythromycin Thiocyanate Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Erythromycin Thiocyanate by Region (2024-2029)
3.3 Global Erythromycin Thiocyanate Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Erythromycin Thiocyanate Production by Region (2018-2029)
3.4.1 Global Erythromycin Thiocyanate Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Erythromycin Thiocyanate by Region (2024-2029)
3.5 Global Erythromycin Thiocyanate Market Price Analysis by Region (2018-2023)
3.6 Global Erythromycin Thiocyanate Production and Value, Year-over-Year Growth
3.6.1 North America Erythromycin Thiocyanate Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Erythromycin Thiocyanate Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Erythromycin Thiocyanate Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Erythromycin Thiocyanate Production Value Estimates and Forecasts (2018-2029)
4 Erythromycin Thiocyanate Consumption by Region
4.1 Global Erythromycin Thiocyanate Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Erythromycin Thiocyanate Consumption by Region (2018-2029)
4.2.1 Global Erythromycin Thiocyanate Consumption by Region (2018-2023)
4.2.2 Global Erythromycin Thiocyanate Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Erythromycin Thiocyanate Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Erythromycin Thiocyanate Consumption by Country (2018-2029)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Erythromycin Thiocyanate Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Erythromycin Thiocyanate Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Erythromycin Thiocyanate Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Erythromycin Thiocyanate Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Erythromycin Thiocyanate Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Erythromycin Thiocyanate Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Erythromycin Thiocyanate Production by Type (2018-2029)
5.1.1 Global Erythromycin Thiocyanate Production by Type (2018-2023)
5.1.2 Global Erythromycin Thiocyanate Production by Type (2024-2029)
5.1.3 Global Erythromycin Thiocyanate Production Market Share by Type (2018-2029)
5.2 Global Erythromycin Thiocyanate Production Value by Type (2018-2029)
5.2.1 Global Erythromycin Thiocyanate Production Value by Type (2018-2023)
5.2.2 Global Erythromycin Thiocyanate Production Value by Type (2024-2029)
5.2.3 Global Erythromycin Thiocyanate Production Value Market Share by Type (2018-2029)
5.3 Global Erythromycin Thiocyanate Price by Type (2018-2029)
6 Segment by Application
6.1 Global Erythromycin Thiocyanate Production by Application (2018-2029)
6.1.1 Global Erythromycin Thiocyanate Production by Application (2018-2023)
6.1.2 Global Erythromycin Thiocyanate Production by Application (2024-2029)
6.1.3 Global Erythromycin Thiocyanate Production Market Share by Application (2018-2029)
6.2 Global Erythromycin Thiocyanate Production Value by Application (2018-2029)
6.2.1 Global Erythromycin Thiocyanate Production Value by Application (2018-2023)
6.2.2 Global Erythromycin Thiocyanate Production Value by Application (2024-2029)
6.2.3 Global Erythromycin Thiocyanate Production Value Market Share by Application (2018-2029)
6.3 Global Erythromycin Thiocyanate Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Kelun Chuanning Biotechnology
7.1.1 Kelun Chuanning Biotechnology Erythromycin Thiocyanate Corporation Information
7.1.2 Kelun Chuanning Biotechnology Erythromycin Thiocyanate Product Portfolio
7.1.3 Kelun Chuanning Biotechnology Erythromycin Thiocyanate Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Kelun Chuanning Biotechnology Main Business and Markets Served
7.1.5 Kelun Chuanning Biotechnology Recent Developments/Updates
7.2 Ercros S.A.
7.2.1 Ercros S.A. Erythromycin Thiocyanate Corporation Information
7.2.2 Ercros S.A. Erythromycin Thiocyanate Product Portfolio
7.2.3 Ercros S.A. Erythromycin Thiocyanate Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Ercros S.A. Main Business and Markets Served
7.2.5 Ercros S.A. Recent Developments/Updates
7.3 HEC Group
7.3.1 HEC Group Erythromycin Thiocyanate Corporation Information
7.3.2 HEC Group Erythromycin Thiocyanate Product Portfolio
7.3.3 HEC Group Erythromycin Thiocyanate Production, Value, Price and Gross Margin (2018-2023)
7.3.4 HEC Group Main Business and Markets Served
7.3.5 HEC Group Recent Developments/Updates
7.4 Envee Drugs Pvt Ltd
7.4.1 Envee Drugs Pvt Ltd Erythromycin Thiocyanate Corporation Information
7.4.2 Envee Drugs Pvt Ltd Erythromycin Thiocyanate Product Portfolio
7.4.3 Envee Drugs Pvt Ltd Erythromycin Thiocyanate Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Envee Drugs Pvt Ltd Main Business and Markets Served
7.4.5 Envee Drugs Pvt Ltd Recent Developments/Updates
7.5 Mehta Api
7.5.1 Mehta Api Erythromycin Thiocyanate Corporation Information
7.5.2 Mehta Api Erythromycin Thiocyanate Product Portfolio
7.5.3 Mehta Api Erythromycin Thiocyanate Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Mehta Api Main Business and Markets Served
7.5.5 Mehta Api Recent Developments/Updates
7.6 Abbvie
7.6.1 Abbvie Erythromycin Thiocyanate Corporation Information
7.6.2 Abbvie Erythromycin Thiocyanate Product Portfolio
7.6.3 Abbvie Erythromycin Thiocyanate Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Abbvie Main Business and Markets Served
7.6.5 Abbvie Recent Developments/Updates
7.7 Ningxia Qiyuan
7.7.1 Ningxia Qiyuan Erythromycin Thiocyanate Corporation Information
7.7.2 Ningxia Qiyuan Erythromycin Thiocyanate Product Portfolio
7.7.3 Ningxia Qiyuan Erythromycin Thiocyanate Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Ningxia Qiyuan Main Business and Markets Served
7.7.5 Ningxia Qiyuan Recent Developments/Updates
7.8 Calyx C & P
7.8.1 Calyx C & P Erythromycin Thiocyanate Corporation Information
7.8.2 Calyx C & P Erythromycin Thiocyanate Product Portfolio
7.8.3 Calyx C & P Erythromycin Thiocyanate Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Calyx C & P Main Business and Markets Served
7.7.5 Calyx C & P Recent Developments/Updates
7.9 Alembic Pharma
7.9.1 Alembic Pharma Erythromycin Thiocyanate Corporation Information
7.9.2 Alembic Pharma Erythromycin Thiocyanate Product Portfolio
7.9.3 Alembic Pharma Erythromycin Thiocyanate Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Alembic Pharma Main Business and Markets Served
7.9.5 Alembic Pharma Recent Developments/Updates
7.10 SM Biomed
7.10.1 SM Biomed Erythromycin Thiocyanate Corporation Information
7.10.2 SM Biomed Erythromycin Thiocyanate Product Portfolio
7.10.3 SM Biomed Erythromycin Thiocyanate Production, Value, Price and Gross Margin (2018-2023)
7.10.4 SM Biomed Main Business and Markets Served
7.10.5 SM Biomed Recent Developments/Updates
7.11 Anuh Pharma
7.11.1 Anuh Pharma Erythromycin Thiocyanate Corporation Information
7.11.2 Anuh Pharma Erythromycin Thiocyanate Product Portfolio
7.11.3 Anuh Pharma Erythromycin Thiocyanate Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Anuh Pharma Main Business and Markets Served
7.11.5 Anuh Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Erythromycin Thiocyanate Industry Chain Analysis
8.2 Erythromycin Thiocyanate Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Erythromycin Thiocyanate Production Mode & Process
8.4 Erythromycin Thiocyanate Sales and Marketing
8.4.1 Erythromycin Thiocyanate Sales Channels
8.4.2 Erythromycin Thiocyanate Distributors
8.5 Erythromycin Thiocyanate Customers
9 Erythromycin Thiocyanate Market Dynamics
9.1 Erythromycin Thiocyanate Industry Trends
9.2 Erythromycin Thiocyanate Market Drivers
9.3 Erythromycin Thiocyanate Market Challenges
9.4 Erythromycin Thiocyanate Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Kelun Chuanning Biotechnology
Ercros S.A.
HEC Group
Envee Drugs Pvt Ltd
Mehta Api
Abbvie
Ningxia Qiyuan
Calyx C & P
Alembic Pharma
SM Biomed
Anuh Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂